OncoSec is a clinical-stage biotechnology company focused on developing ... -at-the-2019-san-antonio-breast-cancer-symposium-300969777.html.
News
- OncoSec to Present Interim Data from Ongoing KEYNOTE-890 Study of TAVO(TM) and ...
- Common Diabetes Medications Tested for Anti-Aging Effects
Newswise — San Antonio, Texas (December 4, 2019) – Two drugs already on ... Texas Biomed is one of the world's leading independent biomedical ...
- UTSA program aims to prevent substance abuse among local middle schoolers
4, 2019 — UTSA is working with a San Antonio middle school on the city's West ... issues in partnership with the San Antonio Metropolitan Health District. ... through integration of biomedical and sociobehavioral science approaches.
- Biothera Pharmaceuticals Phase 2 Triple Negative Breast Cancer Data Selected for Spotlight ...
... Selected for Spotlight Session at San Antonio Breast Cancer Symposium ... Biothera Pharmaceuticals is a privately held biotechnology company ...
- Foundation Medicine Expands Indication for FoundationOne®CDx as a Companion Diagnostic for ...
... presenting new data at this year's San Antonio Breast Cancer Symposium (SABCS) highlighting the ... INDUSTRY KEYWORD: ONCOLOGY HEALTH FDA GENETICS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY.